A high-fat diet catalyzes progression to hyperglycemia in mice with selective impairment of insulin action in Glut4-expressing tissues

Autor: Daniel J. Horan, Hyun Cheol Roh, Aaron C. Ericsson, Surabhi D. Abhyankar, Natalie D. Stull, Xiaocheng C. Dong, Alexander G. Robling, Hongxia Ren, Robert N. Bone, Austin M. Reilly, Shijun Yan, Jason M. Conley, Carmella Evans-Molina, Menghao Huang
Rok vydání: 2022
Předmět:
insulin receptor (INSR)
HFD
high-fat diet

OGTT
oral glucose tolerance test

medicine.medical_treatment
Glucose uptake
ROI
region of interest

Type 2 diabetes
Biochemistry
type 2 diabetes (T2DM)
Insr
insulin receptor

Mice
insulin resistance
Hyperinsulinemia
Insulin
glucose transporter type 4 (GLUT4)
Mice
Knockout

Glucose Transporter Type 4
diabetes
biology
GLUT4
glucose transporter type 4

GIRKO
GLUT4 promoter-driven insulin receptor knockout

FFPE
formalin-fixed paraffin-embedded

IPGTT
intraperitoneal glucose tolerance test

LPS
lipopolysaccharide

MIRKO
muscle-Insr-KO

Research Article
medicine.medical_specialty
glucose metabolism
T2D
type 2 diabetes

Diet
High-Fat

GSIS
glucose-stimulated insulin secretion

Insulin resistance
Diabetes mellitus
Internal medicine
Glucose Intolerance
medicine
Animals
Molecular Biology
micro-CT
micro-computed tomography

NCD
normal chow diet

business.industry
VLDL
very-low-density lipoprotein

nutritional and metabolic diseases
DIO
diet-induced obesity

Cell Biology
medicine.disease
Mice
Inbred C57BL

FIRKO
fat-Insr-KO

Insulin receptor
Endocrinology
Diabetes Mellitus
Type 2

Hyperglycemia
biology.protein
diet
business
metabolism
GLUT4
Zdroj: The Journal of Biological Chemistry
ISSN: 0021-9258
Popis: Insulin resistance impairs postprandial glucose uptake through glucose transporter type 4 (GLUT4) and is the primary defect preceding type 2 diabetes. We previously generated an insulin-resistant mouse model with human GLUT4 promoter-driven insulin receptor knockout (GIRKO) in the muscle, adipose, and neuronal subpopulations. However, the rate of diabetes in GIRKO mice remained low prior to 6 months of age on normal chow diet (NCD), suggesting that additional factors/mechanisms are responsible for adverse metabolic effects driving the ultimate progression of overt diabetes. In this study, we characterized the metabolic phenotypes of the adult GIRKO mice acutely switched to high-fat diet (HFD) feeding in order to identify additional metabolic challenges required for disease progression. Distinct from other diet-induced obesity (DIO) and genetic models (e.g., db/db mice), GIRKO mice remained leaner on HFD feeding, but developed other cardinal features of insulin resistance syndrome. GIRKO mice rapidly developed hyperglycemia despite compensatory increases in β-cell mass and hyperinsulinemia. Furthermore, GIRKO mice also had impaired oral glucose tolerance and a limited glucose-lowering benefit from exendin-4, suggesting that the blunted incretin effect contributed to hyperglycemia. Secondly, GIRKO mice manifested severe dyslipidemia while on HFD due to elevated hepatic lipid secretion, serum triglyceride concentration, and lipid droplet accumulation in hepatocytes. Thirdly, GIRKO mice on HFD had increased inflammatory cues in the gut, which were associated with the HFD-induced microbiome alterations and increased serum lipopolysaccharide (LPS). In conclusion, our studies identified important gene/diet interactions contributing to diabetes progression, which might be leveraged to develop more efficacious therapies.
Databáze: OpenAIRE